Target intelligence / Profile preview

Bacterial catecholate siderophore-iron complex

Molecular classification
Other
01

Overview

The **bacterial catecholate siderophore-iron complex** refers to a stable coordination complex formed when a catecholate-type siderophore, such as enterobactin or bacillibactin, produced by bacteria under iron-limiting conditions, binds tightly to ferric ion (Fe^3+). Siderophores are high-affinity iron-chelating molecules that solubilize and sequester iron from the environment, which is then transported into the bacterial cell via specific outer membrane transporters and periplasmic binding proteins. Catecholate siderophores are characterized by their catechol (dihydroxybenzene) functional groups, contributing to high iron affinity and stable hexadentate (six donor atoms) complexes with Fe^3+[4][5][11]. Once the complex enters the periplasm, iron is typically released through reduction to Fe^2+ or enzymatic hydrolysis of the siderophore scaffold[11]. This process is vital for bacterial growth and virulence, as iron is an essential but often limiting nutrient, especially in host environments where iron is tightly sequestered by host proteins[3][7][8]. **Important structural and mechanistic note:** The term "bacterial catecholate siderophore-iron complex" does not itself denote a single, well-defined molecular target (such as a receptor, transporter, or enzyme) but rather a class of molecular complexes formed by the iron-binding reaction of catecholate siderophores with Fe^3+. It is not a *therapeutic target* in the conventional sense, but the associated pathways (e.g., siderophore biosynthesis, transporters such as FepA, uptake systems, or enzymes hydrolyzing the complex) are established therapeutic targets or points of intervention in antibacterial drug development[9][10][11]. Because the query specifies a *complex* and not a protein or specific molecular target, and because the complex itself is not a receptor, enzyme, or other standard drug target, the entry is marked "is_target: false" and "is_incorrect: true" for direct therapeutic target annotation. For drug discovery purposes, attention should refocus to proteins that bind, transport, or catalyze reactions involving these complexes (like siderophore receptors such as FepA or Fiu, or related ATP-binding cassette [ABC] transporters), not the iron-siderophore complex per se[1][9][10][11].

Other names
Catecholate-type siderophore-iron complexFerric-catecholate siderophore complexFe(III)-catecholate siderophore complexFerric-enterobactin complex (for specific subclasses, e.g., enterobactin)
02

Mechanism of action

Chelation of ferric iron (Fe^3+) by siderophores for bacterial transport and uptake Competitive inhibition of iron acquisition by structurally similar chelators or metal complexes

03

Biological functions

Iron acquisitionIron transportMicrobial survival in iron-limited environments
04

Disease associations

Infection (as siderophore-mediated iron uptake is a crucial virulence factor in many pathogenic bacteria)
05

Safety considerations

Potential off-target chelation of physiological iron leading to disruption of host iron metabolism if leveraged as therapeutic approachRisk of resistance or metabolic adaptation if used as a drug target
06

Interacting drugs

Desferrioxamine (used experimentally as a siderophore competitor or chelator)

1 more in the full profile.

07

Biomarkers

Siderophore levels (as markers for bacterial infection, especially in the context of sepsis or diagnostic panels for infections)

Beyond the preview

Go deeper on Bacterial catecholate siderophore-iron complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial catecholate siderophore-iron complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call